Recent studies suggest that alterations in skeletal muscle (SM) histology and biochemistry play an important role in determining exercise tolerance in patients with chronic heart failure (CHF). This is highlighted by the finding that exercise training, which represents a consumption (VO2) primarily through adaptations in SM. In this proposal we will examine: 1) possible mechanisms for SM """"""""myopathy"""""""" in CHF, 2) relationship of SM alterations to symptoms and peak V02, 3) role of SM in mediating improvements in peak VO2 and symptoms after exercise training, and 4) the clinical utility of exercise training in varied groups of CHF patients. Studies will examine the relationships between SM enzyme activity, histology, contractile protein expression, and mRNA signalling with peak VO2, SM contractile function, SM metabolism during exercise (via 31P-MRI), and SM oxygenation during exercise (via near infrared-spectrophotometry) in patients with CHF and in normal controls. The following specific hypotheses will be addressed: Hypothesis 1: Alterations in SM metabolism are present during isometric and isotonic exercise in patients with CHF and are related to alterations in SM enzyme activity, histology and contractile protein content. Hypothesis 2: The relationship of SM isometric force to muscle metabolism (measured by 31p-MRI), is altered in CHF. Hypothesis 3: Reduced SM performance in CHF is related to alterations in contractile protein expression and sarcoplasmic reticulum functioning. Hypothesis 4: Alterations in SM protein expression are associated with changes in mRNA expression. Hypothesis 5: Exercise training reverses abnormalities in SM contractility, biochemistry and histology, and improves symptoms and peak VO2 in CHF. Hypothesis 6: In patients with CHF and angina, exercise training coupled with intensive risk factor modifications improves exercise performance and symptoms. Hypothesis 7: Contractile dysfunction in SM is present in patients with CHF and normal LV ejection fractions (diastolic LV dysfunction) and is related to alterations in SM biochemistry and histology.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL054314-04
Application #
6273037
Study Section
Project Start
1998-01-26
Project End
1998-12-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Dun, N J; Le Dun, S; Chen, C T et al. (2000) Orexins: a role in medullary sympathetic outflow. Regul Pept 96:65-70
Palmer, T M; Stiles, G L (2000) Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A(3) adenosine receptor. Mol Pharmacol 57:539-45
Palmer, T M; Stiles, G L (1999) Stimulation of A(2A) adenosine receptor phosphorylation by protein kinase C activation: evidence for regulation by multiple protein kinase C isoforms. Biochemistry 38:14833-42
Brahmajothi, M V; Campbell, D L; Rasmusson, R L et al. (1999) Distinct transient outward potassium current (Ito) phenotypes and distribution of fast-inactivating potassium channel alpha subunits in ferret left ventricular myocytes. J Gen Physiol 113:581-600
Ren, H; Stiles, G L (1999) Dexamethasone stimulates human A1 adenosine receptor (A1AR) gene expression through multiple regulatory sites in promoter B. Mol Pharmacol 55:309-16
Ren, H; Stiles, G L (1998) A single-stranded DNA binding site in the human A1 adenosine receptor gene promoter. Mol Pharmacol 53:43-51
Palmer, T M; Harris, C A; Coote, J et al. (1997) Induction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A3 adenosine receptor. Mol Pharmacol 52:632-40
Brahmajothi, M V; Morales, M J; Rasmusson, R L et al. (1997) Heterogeneity in K+ channel transcript expression detected in isolated ferret cardiac myocytes. Pacing Clin Electrophysiol 20:388-96
Palmer, T M; Stiles, G L (1997) Structure-function analysis of inhibitory adenosine receptor regulation. Neuropharmacology 36:1141-7
Rasmusson, R L; Wang, S; Castellino, R C et al. (1997) The beta subunit, Kv beta 1.2, acts as a rapid open channel blocker of NH2-terminal deleted Kv1.4 alpha-subunits. Adv Exp Med Biol 430:29-37

Showing the most recent 10 out of 21 publications